{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:25:38Z","timestamp":1788992738699,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12288-024-01898-5","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T07:08:53Z","timestamp":1729235333000},"page":"494-503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Outcome of Childhood and Adolescents and Young Adults ALL Treated with ALL IC-BFM 2009 Protocol\u2013A Single-Center Experience in India"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7002-3107","authenticated-orcid":false,"given":"Karthik","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sashi Kant","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhasaketan","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanimozhi","family":"Rajamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paras","family":"Satadeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyavadhana","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Dhamija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttam Kumar","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"key":"1898_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-020-00170-6","author":"Y Dong","year":"2020","unstructured":"Dong Y, Shi O, Zeng Q et al (2020) Leukemia incidence trends at the global, regional, and national level between 1990 and 2017. Exp Hematol Oncol. https:\/\/doi.org\/10.1186\/s40164-020-00170-6","journal-title":"Exp Hematol Oncol"},{"issue":"4","key":"1898_CR2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/oxfordjournals.bmb.a011577","volume":"52","author":"CA Stiller","year":"1996","unstructured":"Stiller CA, Parkin DM (1996) Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull 52(4):682\u2013703","journal-title":"Br Med Bull"},{"issue":"6","key":"1898_CR3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","volume":"18","author":"E Steliarova-Foucher","year":"2017","unstructured":"Steliarova-Foucher E, Colombet M, Ries LA, Moreno F, Dolya A, Bray F, Hesseling P, Shin HY, Stiller CA, Bouzbid S, Hamdi-Cherif M (2017) International incidence of childhood cancer, 2001\u201310: a population-based registry study. Lancet Oncol 18(6):719\u2013731","journal-title":"Lancet Oncol"},{"issue":"17","key":"1898_CR4","first-page":"2101","volume":"127","author":"A M\u00f6ricke","year":"2016","unstructured":"M\u00f6ricke A, Zimmermann M, Valsecchi MG, Stanulla M, Biondi A, Mann G, Locatelli F, Cazzaniga G, Niggli F, Arico M, Bartram CR (2016) Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. Blood J Am Soc Hematol 127(17):2101\u20132112","journal-title":"Blood J Am Soc Hematol"},{"issue":"3","key":"1898_CR5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12288-020-01354-0","volume":"37","author":"T Cherian","year":"2021","unstructured":"Cherian T, John R, Joseph LL et al (2021) Complete peripheral blast clearance is superior to the conventional cut-off of 1000\/\u00b5L in predicting relapse in pediatric pre-B acute lymphoblastic leukemia. Indian J Hematol Blood Transfus 37(3):366\u2013371","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"6","key":"1898_CR6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1365-2141.2005.05509.x","volume":"129","author":"CD Mitchell","year":"2005","unstructured":"Mitchell CD, Richards SM, Kinsey SE, Lilleyman J, Vora A, Eden TO (2005) Medical Research Council childhood leukaemia working party. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. British J Haematol. 129(6):734\u2013745","journal-title":"British J Haematol."},{"issue":"2","key":"1898_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/pbc.25793","volume":"63","author":"Y Matloub","year":"2016","unstructured":"Matloub Y, Stork L, Asselin B, Hunger SP, Borowitz M, Jones T, Bostrom B, Gastier-Foster JM, Heerema NA, Carroll A, Winick N (2016) Outcome of children with standard-risk T-lineage acute lymphoblastic leukemia\u2014Comparison among different treatment strategies. Pediatr Blood Cancer 63(2):255\u2013261","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"1898_CR8","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1038\/sj.leu.2401939","volume":"14","author":"PS Gaynon","year":"2000","unstructured":"Gaynon PS, Trigg ME, Heerema NA, Sensel MG, Sather HN, Hammond GD, Bleyer WA (2000) Children\u2019s Cancer Group trials in childhood acute lymphoblastic leukemia: 1983\u20131995. Leukemia 14(12):2223\u20132233","journal-title":"Leukemia"},{"issue":"3","key":"1898_CR9","first-page":"825","volume":"99","author":"BJ Lange","year":"2002","unstructured":"Lange BJ, Bostrom BC, Cherlow JM, Sensel MG, La MK, Rackoff W, Heerema NA, Wimmer RS, Trigg ME, Sather HN (2002) Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children\u2019s Cancer Group. Blood J Am Soc Hematol 99(3):825\u2013833","journal-title":"Blood J Am Soc Hematol"},{"issue":"5","key":"1898_CR10","first-page":"2548","volume":"111","author":"NL Seibel","year":"2008","unstructured":"Seibel NL, Steinherz PG, Sather HN, Nachman JB, DeLaat C, Ettinger LJ, Freyer DR, Mattano LA Jr, Hastings CA, Rubin CM, Bertolone K (2008) Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group. Blood J Am Soc Hematol 111(5):2548\u20132555","journal-title":"Blood J Am Soc Hematol"},{"issue":"20","key":"1898_CR11","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1200\/JCO.2015.62.4544","volume":"34","author":"EC Larsen","year":"2016","unstructured":"Larsen EC, Devidas M, Chen S, Salzer WL, Raetz EA, Loh ML, Mattano LA Jr, Cole C, Eicher A, Haugan M, Sorenson M (2016) Dexamethasone and high-dose methotrexate improve outcome for children and young adults with high-risk B-acute lymphoblastic leukemia: a report from Children\u2019s Oncology Group Study AALL0232. J Clin Oncol 34(20):2380","journal-title":"J Clin Oncol"},{"issue":"5","key":"1898_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/08880018.2021.2005725","volume":"39","author":"K Vijayasekharan","year":"2022","unstructured":"Vijayasekharan K, Kc A, Prasad M, Dhamne C, Roy Moulik N, Shet T, Sridhar E, Laskar S, Kembhavi S, Shah S, Gujral S (2022) Clinical outcomes and prognostic factors in children with B-cell lymphoblastic lymphoma (LBL) treated according to on modified BFM-90 protocol: experience from a Tertiary cancer care center in India. Pediatr Hematol Oncol 39(5):427\u2013440","journal-title":"Pediatr Hematol Oncol"},{"issue":"19","key":"1898_CR13","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1200\/JCO.22.01760","volume":"41","author":"M Campbell","year":"2023","unstructured":"Campbell M, Kiss C, Zimmermann M, Riccheri C, Kowalczyk J, Felice MS, Kuzmanovic M, Kovacs G, Kosmidis H, Gonzalez A, Bilic E (2023) Childhood acute lymphoblastic leukemia: results of the randomized acute lymphoblastic leukemia intercontinental-Berlin-Frankfurt-M\u00fcnster 2009 trial. J Clin Oncol 41(19):3499\u20133511","journal-title":"J Clin Oncol"},{"issue":"4","key":"1898_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26281","volume":"64","author":"A Trehan","year":"2017","unstructured":"Trehan A, Bansal D, Varma N, Vora A (2017) Improving outcome of acute lymphoblastic leukemia with a simplified protocol: report from a tertiary care center in north India. Pediatr Blood Cancer 64(4):e26281","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1898_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1470-2045(12)70600-9","volume":"14","author":"A Vora","year":"2013","unstructured":"Vora A, Goulden N, Wade R, Mitchell C, Hancock J, Hough R, Rowntree C, Richards S (2013) Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. Lancet Oncol 14(3):199\u2013209","journal-title":"Lancet Oncol"},{"issue":"9","key":"1898_CR16","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1182\/blood.V84.9.3122.3122","volume":"84","author":"A Reiter","year":"1994","unstructured":"Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D (1994) Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84(9):3122\u20133133","journal-title":"Blood"},{"issue":"8","key":"1898_CR17","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3324\/haematol.12365","volume":"93","author":"A Manabe","year":"2008","unstructured":"Manabe A, Ohara A, Hasegawa D, Koh K, Saito T, Kiyokawa N, Kikuchi A, Takahashi H, Ikuta K, Hayashi Y, Hanada R (2008) Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children\u2019s Cancer Study Group Study L99\u201315. Haematologica 93(8):1155\u20131160","journal-title":"Haematologica"},{"issue":"3","key":"1898_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/1042819021000055048","volume":"44","author":"S Yetgin","year":"2003","unstructured":"Yetgin S, \u00c7etin M, Gurgey A (2003) The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia. Leuk Lymphoma 44(3):489\u2013495","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"1898_CR19","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3324\/haematol.2011.047613","volume":"97","author":"M Lauten","year":"2012","unstructured":"Lauten M, M\u00f6ricke A, Beier R et al (2012) Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia. Haematologica 97(7):1048\u20131056","journal-title":"Haematologica"},{"issue":"4","key":"1898_CR20","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s12288-019-01119-4","volume":"35","author":"G Kamat","year":"2019","unstructured":"Kamat G, Subramanian K, Apte S (2019) Correlation of day 8 steroid response with bone marrow status measured on days 14 and 35, in patients with acute lymphoblastic leukemia being treated with BFM Protocol. Indian J Hematol Blood Transfus 35(4):635\u2013639","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"11","key":"1898_CR21","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/0145-2126(95)00076-3","volume":"19","author":"C Sebban","year":"1995","unstructured":"Sebban C, Browman GP, Lepage E, Fi\u00e8re D (1995) Prognostic value of early response to chemotherapy assessed by the day 15 bone marrow aspiration in adult acute lymphoblastic leukemia: a prospective analysis of 437 cases and its application for designing induction chemotherapy trials. Leuk Res 19(11):861\u2013868","journal-title":"Leuk Res"},{"key":"1898_CR22","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3389\/fonc.2020.00923","volume":"10","author":"LE Radu","year":"2020","unstructured":"Radu LE, Colita A, Pasca S et al (2020) Day 15 and day 33 minimal residual disease assessment for acute lymphoblastic leukemia patients treated according to the BFM ALL IC 2009 protocol: single-center experience of 133 cases. Front Oncol. 10:923","journal-title":"Front Oncol."},{"issue":"8","key":"1898_CR23","first-page":"964","volume":"126","author":"MJ Borowitz","year":"2015","unstructured":"Borowitz MJ, Wood BL, Devidas M, Loh ML, Raetz EA, Salzer WL, Nachman JB, Carroll AJ, Heerema NA, Gastier-Foster JM, Willman CL (2015) Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children\u2019s Oncology Group study AALL0232. Blood J Am Soc Hematol 126(8):964\u2013971","journal-title":"Blood J Am Soc Hematol"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-024-01898-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12288-024-01898-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-024-01898-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T23:25:02Z","timestamp":1757114702000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12288-024-01898-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1898"],"URL":"https:\/\/doi.org\/10.1007\/s12288-024-01898-5","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"value":"0971-4502","type":"print"},{"value":"0974-0449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors have anything to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}